申请人:AVENTIS PHARMA INC
公开号:WO2005026175A1
公开(公告)日:2005-03-24
Thienopyrazoles, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).
噻唑并吡唑类化合物,其制备方法,包含这些化合物的药物组合物,以及它们在治疗可通过抑制蛋白激酶,特别是白细胞介素-2诱导酪氨酸激酶(ITK)而调节的疾病状态中的药用。